News

Dulcolax, Colon Cancer Alliance raises $120,000 in Philadelphia Undy 5000 5K Run/Walk

BY Michael Johnsen

PHILADELPHIA — The Undy 5000 5K Run/Walk, presented by Dulcolax, returned here for the fifth consecutive year to help raise funds for colon cancer research. Almost 1,000 participants ran in their underwear as a tongue-in-cheek reference to the area affected by colon cancer, raising $120,000 for Colon Cancer community programs.

The Philadelphia Undy 5000 featured the Colon Cancer Alliance’s Inflatable Colon; a giant, walk-through colon that shows the various stages of colon cancer, including descriptions about Crohn’s disease and Colitis. 

The Undy 5000 will be held in 16 cities across the country this year to educate the public about colon cancer, promote screenings and encourage people to talk about the disease. Instead of raceday T-shirts, all registered participants receive a commemorative pair of Undy 5000 boxers. It is a family-friendly event open to all ages, and in addition to the 5K, there is a 1-mile fun run. CCA hosts the event.

Shop Rite stores joined Boehringer-Ingelheim, which owns the Dulcolax brand, and the CCA to promote the race and raise awareness around colon cancer. Shop Rite also offered specially marked Dulcolax boxes, containing information about the importance of getting screened for colon cancer.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

J&J seeks FDA approval for intravenous Simponi

BY Alaric DeArment

HORSHAM, Pa. — A subsidiary of Johnson & Johnson is hoping to gain Food and Drug Administration approval for a new formulation of one of its drugs.

Janssen Biotech announced that it had filed an application with the FDA seeking approval for an intravenous formulation of Simponi (golimumab) in adults with moderately to severely active rheumatoid arthritis, which affects an estimated 1.5 million Americans.

The FDA approved the subcutaneously injected formulation of Simponi in April 2009 for moderately to severely active rheumatoid arthritis, active psoriatic arthritis and active ankylosing spondylitis.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Actress Marg Helgenberger to appear in Safeway Foundation breast cancer campaign

BY Michael Johnsen

LOS ANGELES — Actress and Stand Up To Cancer ambassador Marg Helgenberger will appear in a new public service campaign on behalf of The Safeway Foundation and Stand Up To Cancer, the companies announced Wednesday.

Helgenberger, known for her role as Catherine Willows on the CBS drama "CSI: Crime Scene Investigation," will appear in both a print and 30-second broadcast public service announcement in direct support of the campaign.

Debuting the end of September, the public service campaign will coincide with Safeway’s annual in-store breast cancer awareness fundraiser, which offers customers multiple opportunities to donate at more than 1,600 Safeway stores across the United States and Canada. The public service campaign will extend through October.

At the center of the public service campaign is a limited-edition, breast cancer awareness reusable shopping bag. The bag will be available for purchase at all Safeway locations, including Vons, Pavilions, Tom Thumb, Randalls, Dominick’s and Carrs stores, as well as online at Safewayfoundation.org. Two dollars from the sale of the $2.99 reusable bag will go directly to breast cancer research. Additionally, Safeway shoppers will have a chance to make a separate donation at checkout stands.

"As the daughter of a breast cancer survivor, I am deeply committed to the fight against this disease," Helgenberger said. "I am proud to take a stand on behalf of my mother, and in support of all the women and families who have been affected by breast cancer."

To date, Safeway and The Safeway Foundation have raised $102 million in support of breast cancer research.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES